-
Patients in peril as KEM runs out of haemophilia drugs
06 Aug 2025 08:06 GMT
… hospital, as it lacked Factor VII needed to arrest postpartum … Like KEM, those with medical colleges and other advanced … doctors trained to treat haemophilia patients. After receiving factor treatment … back on July 16, stating, “Since a large number …
-
Mumbai's KEM Hospital Lacks Haemophilia Medications, Forcing Costly Private Alternatives
06 Aug 2025 06:57 GMT
… patients being denied treatment because of insufficient vital medications. A significant instance … institution, since KEM was missing Factor VII essential for managing postpartum bleeding … factors and to replenish vital medications at KEM for delivering …
-
An Increased Plasma D-Dimer Levels During Different Stages of Normal and Complicated Pregnancies Among Women in Bisha, Saudi Arabia
06 Aug 2025 09:13 GMT
… in guiding the anticoagulant treatments and minimizing the incidence … factors such as fibrinogen, factor VII, VIII, and X, … measurement to guide anticoagulant treatment in recurrent pregnancy loss … et al. A randomized trial of diagnostic strategies after …
-
After months of delay, Maharashtra approves ₹45 crore for haemophilia drugs
20 Jun 2025 09:06 GMT
… treatment of haemophilia. Bottles of Factor VIII, one of the drugs … to treat haemophilia. (Wikimedia Commons) This includes Factor VII … medical colleges like KEM disrupted access to life-saving treatment … still threaten treatment continuity. “Companies …
-
'Separate treatment protocols needed for acquired and congenital hemophilia A'
24 Apr 2025 06:16 GMT
… pathogenesis, clinical presentation, and treatment strategies.
“Acquired hemophilia A … mainstay of treatment for acquired hemophilia A. These drugs promote … Common examples include recombinant activated factor VII (rFVIIa) and activated prothrombin …
-
FDA approves fitusiran for hemophilia A, B patients aged 12 years and up
28 Mar 2025 22:15 GMT
… patients (with or without factor VII or IX inhibitors) who … FDA’s Center for Drug Evaluation and Research.
“This new treatment … received on-demand treatment with medicines known as “bypassing … the two randomized clinical trials.
Estimated annualized bleeding …
-
Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress
07 Feb 2025 14:13 GMT
… a clinical-stage biotechnology company developing novel … and support future clinical trials.
Hemab' … of those bleeds requiring medical treatment. These bleeding episodes … like Glanzmann thrombasthenia, Factor VII Deficiency, Von Willebrand Disease …
-
The Mechanisms of Sepsis Induced Coagulation Dysfunction and Its Treatment
03 Feb 2025 05:03 GMT
… TFPI-related medications have concluded clinical trials in recent … complement activation. Pharmacological treatments, including statins, vitamin C, … transfusions, and vasoactive drugs to maintain stable … FVa, Factor Va; FVII, Factor VII; FVIIa, Factor VIIa; …
-
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy
17 Jan 2025 14:00 GMT
… the US Food and Drug Administration (FDA) in 2001.136–138 … inhibitor is an inhibitor of factor VII-activating protease. J Thromb … sepsis: potential new options for treatment. Pharmaceuticals. 2023;16(2):271. … model. Artif Cells Nanomed Biotechnol. 2023;51(1):33 …
-
Hemophilia Patients In Maharashtra Face Crisis As Government Hospitals Run Out Of Medicines
13 Dec 2024 20:09 GMT
… saving medications, including Factor VIII, Factor IX, Factor VII, and … unable to receive the treatment they desperately need. Additionally … endure frequent and disruptive treatments. “This neglect … state funding for hemophilia treatment, which currently stands …